Markets
Blue Water Acquisition Corp. III (BLUWW)
BLUWWNASDAQ-GMN/A
$0.0800
+0.0084 (+11.73%) today
Regular session, Nov 17, 1:28 PM ET
+11.73% 1D
- Market cap
- $579.6k
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $0.0700 to $0.0800
- 52-week range
- $0.0682 to $0.8500
- Average volume
- –
- Previous close
- $0.0716
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$517.0k | -$354.0k | -$198.0k | -$242.0k |
| Net income | $2.01m | $1.93m | $2.10m | $2.13m |
News
8 latest- Stocks Pressured by Weakness in Software and Health Insurance StocksBarchart · 2 minutes ago
- Reliance Global (XGPU) Q3 2026 Earnings Call TranscriptThe Motley Fool · 6 minutes ago
- Why Micron Stock Keeps On Going DownThe Motley Fool · 6 minutes ago
- Stock Indexes Settle Sharply Lower on Big Tech DrubbingBarchart · 8 minutes ago
- Tuesday Sector Laggards: Application Software, Information Technology Services BNK Invest · 10 minutes ago
- Tuesday Sector Leaders: Sporting Goods & Activities, Precious Metals BNK Invest · 10 minutes ago
- Notable Tuesday Option Activity: COIN, WDAY, BIIBBNK Invest · 10 minutes ago
- Noteworthy Tuesday Option Activity: AVGO, AMZN, NOWBNK Invest · 10 minutes ago
The company
Clarus Therapeutics, Inc. is a men's specialty pharmaceutical company with a mission to help men with hypogonadism, a condition associated with a deficiency or absence of endogenous testosterone. We are working hard every day to make a difference in the lives of affected men. As a privately-held company, Clarus Therapeutics is backed by Thomas, McNerney & Partners, L.P., H.I.G. BioHealth Partners, ProQuest Investments, C-Bridge Capital Partners, LLC, BVCF Management, Ltd. and Pavilion Capital Pte Ltd. To learn more, visit clarustherapeutics.com.
- Sector
- N/A
- Industry
- N/A
- Exchange
- NASDAQ-GM
- Region
- North America
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.